跳至主要内容
临床试验/NCT03088462
NCT03088462已完成不适用

LiveWell: A Mobile Intervention for Bipolar Disorder

Northwestern University4 个研究点 分布在 1 个国家目标入组 205 人开始时间: 2017年3月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
205
试验地点
4
主要终点
Longitudinal Interval Follow-up Evaluation-Clinical Monitoring Form: Clinical Status

研究概览

简要总结

LiveWell is a study evaluating the use of smartphones to better understand and improve the treatment of bipolar disorder. Our goal is to increase access to psychosocial interventions and improve their effectiveness in reducing symptoms and preventing mood episodes.

详细描述

A single blind, randomized controlled trial (N = 200, 2:3 ratio of usual care vs usual care and intervention) will be conducted in clinical practices around Chicago and Minneapolis. Eligible participants are adult bipolar 1 disorder patients not experiencing a current mood episode with a history of at least one acute episode in the last two years who are in treatment with a psychiatrist.

The primary clinical outcome will be time to relapse, and the secondary outcomes will be percent time symptomatic, symptom severity, and quality of life.

Participation in the study lasts for 12 months. Participants are asked to carry a smartphone with them whenever they leave home and wear a wristwatch for measuring activity all day every day. Participants are also asked to complete a series of telephone assessments and may be asked to complete daily check-ins on a smartphone and work with a health coach.

Participants will need to attend two in-person clinic visits at 680 N Lake Shore Drive, Chicago IL 60611 Suite 1520 or at 3311 E Old Shakopee Rd, Bloomington, MN 55425.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults 18-65 years
  • Bipolar Disorder Type I
  • Minimum of 1 acute episode in the last 2 years

排除标准

  • Not receiving psychiatric care
  • Current mood episode
  • Current substance use disorder (within the last 3 months)
  • Current severe suicidal ideation or a recent serious suicide attempt (within the last 3 months)
  • Inability to speak and read English
  • Visual, hearing, voice, cognitive or motor impairment that would prevent completion of study and treatment procedures
  • Participants will need to attend two in-person clinic visits at 680 N Lake Shore Drive, Chicago IL 60611 Suite 1520 or at 3311 E Old Shakopee Rd, Bloomington, MN 55425.

结局指标

主要结局

Longitudinal Interval Follow-up Evaluation-Clinical Monitoring Form: Clinical Status

时间窗: Up to 48 weeks

Semi-structured interview designed to assess clinical status allowing determination of time to relapse (onset of a mood episode). Clinical Status: episode = depression, mania, hypomania, mixed; continued symptomatic (≥ 3 moderate symptoms without recovery), recovering (≤ 2 moderate symptoms, ≤ 8 weeks), prodromal (≥ 3 moderate symptoms after recovery); recovered (≤ 2 moderate symptoms, ≥ 8 weeks).

次要结局

  • Change in World Health Organization Quality of Life Scale (BREF)(At 0, 24 and 48 weeks)
  • Longitudinal Interval Follow-up Evaluation-Clinical Monitoring Form: Symptom Severity(48 weeks)
  • Change in Quick Inventory of Depressive Symptomatology-Clinician Rating(At 0, 8, 16, 24, 32, 40 and 48 weeks)
  • Change in Young Mania Rating Scale(At 0, 8, 16, 24, 32, 40 and 48 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Evan Goulding

Assistant Professor, Department of Psychiatry and Behavioral Sciences

Northwestern University

研究点 (4)

Loading locations...

相似试验